Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to -$665997.0.

  • Coya Therapeutics' Other Operating Expenses rose 3814.36% to -$665997.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 3340.87%. This contributed to the annual value of -$4.6 million for FY2024, which is 983.73% down from last year.
  • Coya Therapeutics' Other Operating Expenses amounted to -$665997.0 in Q3 2025, which was up 3814.36% from -$1.5 million recorded in Q2 2025.
  • Coya Therapeutics' Other Operating Expenses' 5-year high stood at $350000.0 during Q2 2023, with a 5-year trough of -$1.5 million in Q2 2025.
  • For the 3-year period, Coya Therapeutics' Other Operating Expenses averaged around -$843242.3, with its median value being -$1.0 million (2024).
  • In the last 5 years, Coya Therapeutics' Other Operating Expenses crashed by 61346.42% in 2024 and then skyrocketed by 3814.36% in 2025.
  • Over the past 3 years, Coya Therapeutics' Other Operating Expenses (Quarter) stood at $193186.0 in 2023, then plummeted by 613.46% to -$991941.0 in 2024, then skyrocketed by 32.86% to -$665997.0 in 2025.
  • Its last three reported values are -$665997.0 in Q3 2025, -$1.5 million for Q2 2025, and -$1.3 million during Q1 2025.